AbebeFSchneiderMAsratBAmbawF.Multimorbidity of chronic non-communicable diseases in low- and middle-income countries: a scoping review. J Comorb. 2020;10:2235042X20961919.
2.
AlbarqouniLPalagamaSChaiJ, et al. Overuse of medications in low- and middle-income countries: a scoping review. Bull World Health Organ. 2023;101(1):36-61D.
3.
Basto-AbreuABarrientos-GutierrezTWadeAN, et al. Multimorbidity matters in low and middle-income countries. J Multimorb Comorb. 2022;12:26335565221106074.
4.
Bosnjak PasicMVidrihBSaracH, et al. Clinical trials in developing countries - ethical considerations. Psychiatr Danub. 2018;30(3):285-291.
5.
JalaliRNogueira-RodriguesADasASirohiBPandaPK.Drug development in low- and middle-income countries: opportunity or exploitation?Am Soc Clin Oncol Educ Book. 2022;42:1-8.
6.
RodeoSA.Marketing of unproven and unapproved regenerative medicine therapies. Sports Health. 2024;16(3):312-314.
